Joanna Kopecka

Turin, 10125, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 105 publications

(S,S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((1-(pyridin-4-yl)ethyl)amino)propan-2-yl)-1H-indole-2-carboxamide, a New Dishevelled 1 and P-Glycoprotein Dual Inhibitor as a Anticancer Agent.

(S,S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((1-(pyridin-4-yl)ethyl)amino)propan-2-yl)-1H-indole-2-carboxamide, a New Dishevelled 1 and P-Glycoprotein Dual Inhibitor as a Anticancer Agent.

Journal: Journal of medicinal chemistry
Published: June 12, 2026

Retraction notice to "FS536, a novel nitric oxide-releasing doxorubicin hybrid, reverts multidrug resistance in lung cancer cells" [Journal of Controlled Release 382 (2025) 113732].

Retraction notice to "FS536, a novel nitric oxide-releasing doxorubicin hybrid, reverts multidrug resistance in lung cancer cells" [Journal of Controlled Release 382 (2025) 113732].

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: May 09, 2026

Correction: Kopecka et al. Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death. Cells 2020, 9, 1033.

Correction: Kopecka et al. Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death. Cells 2020, 9, 1033.

Journal: Cells
Published: April 21, 2026

Corrigendum to 'A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells' [Journal of Controlled Release 149(2) (2011) 196-205].

Corrigendum to 'A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells' [Journal of Controlled Release 149(2) (2011) 196-205].

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 10, 2026

Correction to "First-In-Class Thiosemicarbazone Metal Complexes Targeting the Sigma-2 Receptor (S2R) as an Innovative Strategy against Pancreatic Cancer".

Correction to "First-In-Class Thiosemicarbazone Metal Complexes Targeting the Sigma-2 Receptor (S2R) as an Innovative Strategy against Pancreatic Cancer".

Journal: Journal of medicinal chemistry
Published: January 16, 2026

Editorial: Tumor-host interactions: metabolic and signaling pathways altered in cancer, immune and stromal cells.

Editorial: Tumor-host interactions: metabolic and signaling pathways altered in cancer, immune and stromal cells.

Journal: Frontiers in molecular biosciences
Published: December 30, 2025

Targeting a novel metabolic vulnerability of non-small cell lung cancer to fatty acid oxidation surmounts chemoresistance.

Targeting a novel metabolic vulnerability of non-small cell lung cancer to fatty acid oxidation surmounts chemoresistance.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: December 13, 2025

Orange-Derived Extracellular Vesicles: Characterization and Therapeutic Applications in Normal and Diabetic Wound Healing in In Vivo Models.

Orange-Derived Extracellular Vesicles: Characterization and Therapeutic Applications in Normal and Diabetic Wound Healing in In Vivo Models.

Journal: Cells
Published: December 13, 2025

4-(5-Chloro-3-(3,4,5-trimethoxybenzoyl)-1H-indol-1-yl)benzenesulfonamide: A Novel Polypharmacology Agent to Target Carbonic Anhydrase IX and XII With Improved Selectivity, Wnt/β-Catenin Signaling Pathway, and P-Glycoprotein.

4-(5-Chloro-3-(3,4,5-trimethoxybenzoyl)-1H-indol-1-yl)benzenesulfonamide: A Novel Polypharmacology Agent to Target Carbonic Anhydrase IX and XII With Improved Selectivity, Wnt/β-Catenin Signaling Pathway, and P-Glycoprotein.

Journal: ChemMedChem
Published: November 05, 2025

TGF-β Inhibition Through Combinatory Strategies Suppresses Proliferation and Invasiveness in Malignant Pleural Mesothelioma.

TGF-β Inhibition Through Combinatory Strategies Suppresses Proliferation and Invasiveness in Malignant Pleural Mesothelioma.

Journal: International journal of molecular sciences
Published: October 10, 2025

New dimension of ciprofloxacin hybrids: Synthesis, characterization and anticancer evaluation of newly C3-modified ciprofloxacin derivatives.

New dimension of ciprofloxacin hybrids: Synthesis, characterization and anticancer evaluation of newly C3-modified ciprofloxacin derivatives.

Journal: Bioorganic chemistry
Published: May 29, 2025

Two are better than one: A case study of the biferrocenyl-thymidine "click" conjugate biFcT as novel ferroptosis-inducing agent in lung cancer cells.

Two are better than one: A case study of the biferrocenyl-thymidine "click" conjugate biFcT as novel ferroptosis-inducing agent in lung cancer cells.

Journal: Bioorganic chemistry
Published: March 23, 2025
Showing 1-12 of 105

Last Updated: 09/26/2026